Relapsed Acute Lymphoblastic Leukemia (ALL) Recruiting Phase 1 / 2 Trials for Cytarabine (DB00987)

Back to Relapsed Acute Lymphoblastic Leukemia (ALL)

Also known as: Acute Lymphoblastic Leukemia, in Relapse / Relapsed ALL / Relapsed Acute Lymphoblastic Leukemia / Acute, relapsed Lymphoblastic Leukemia

Indication	Status	Phase
DBCOND0069491 (Relapsed Acute Lymphoblastic Leukemia (ALL))	Recruiting	1 / 2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05658640	HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies	Treatment	Cyclophosphamide (DB00531) Cytarabine (DB00987) Dexamethasone (DB01234) Trametinib (DB08911)